Validation of the Turkish version of the <scp>DOSE‐Nonadherence</scp> measure among patients with cardiometabolic conditions-Reference-Cited by-同舟云学术

Validation of the Turkish version of the DOSE‐Nonadherence measure among patients with cardiometabolic conditions

Published:2022-06-23 Issue:10 Volume:47 Page:1636-1643
ISSN:0269-4727
Container-title:Journal of Clinical Pharmacy and Therapeutics
language:en
Short-container-title:Clinical Pharmacy Therapeu

Author:

Yagmur Merve¹,Ay Pınar²,Sancar Mesut¹,Voils Corrine I.³⁴,Okuyan Betul¹^ORCID

Affiliation:

1. Department of Clinical Pharmacy, Faculty of Pharmacy Marmara University Istanbul Turkey

2. Department of Public Health, School of Medicine Marmara University Istanbul Turkey

3. William S Middleton Memorial Veterans Hospital Madison Wisconsin USA

4. Department of Surgery University of Wisconsin School of Medicine and Public Health Madison Wisconsin USA

Funder

U.S. Department of Veterans Affairs

Publisher

Hindawi Limited

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcpt.13714

Reference25 articles.

1. World Health Organization. (2017)Tackling NCDs: 'best buys' and other recommended interventions for the prevention and control of noncommunicable diseases. Accessed August 31 2020.https://www.who.int/publications/i/item/WHO-NMH-NVI-17.9

2. Assessment of medication knowledge and adherence among patients under oral chronic medication treatment in community pharmacy settings

3. Factors Associated with Non-Adherence to Drugs in Patients with Chronic Diseases Who Go to Pharmacies in Spain

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reliability and validity of the Turkish version of the medication practical barriers to adherence questionnaire in patients with chronic diseases;European Journal of Clinical Pharmacology;2024-08-07

2. Validating a Self-Reported Medication Nonadherence Measure in the Context of Multiple Chronic Diseases and Routes of Medication Administration Among Patients with Type 2 Diabetes;Patient Preference and Adherence;2022-11